Mayne Pharma Group Limited (ASX:MYX – Get Rating) insider Patrick Blake bought 3,097 shares of the firm's stock in a transaction on Thursday, April 13th. The stock was acquired at an average cost of A$4.07 ($2.73) per share, with a total value of A$12,592.40 ($8,451.28).
Mayne Pharma Group Price Performance
The company has a quick ratio of 0.62, a current ratio of 1.45 and a debt-to-equity ratio of 10.18.
Get Mayne Pharma Group alerts:About Mayne Pharma Group
(Get Rating)
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products.
Read More
- Finding New Technology to Invest in: A Guide
- Genuine Parts Company Is Genuinely A Good Buy
- Healthcare Sector: Overview and Keys to Investing
- Can D.R. Horton Shares Raise The Roof, Or Is This The Ceiling?
- American Express Growth Riding On Joyful Consumer Spending
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.